Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

10x Genomics (TXG) Return on Invested Capital (2019 - 2025)

10x Genomics (TXG) has disclosed Return on Invested Capital for 7 consecutive years, with 0.08% as the latest value for Q4 2025.

  • Quarterly Return on Invested Capital rose 19.0% to 0.08% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.08% through Dec 2025, up 19.0% year-over-year, with the annual reading at 0.09% for FY2025, 19.0% up from the prior year.
  • Return on Invested Capital hit 0.08% in Q4 2025 for 10x Genomics, up from 0.12% in the prior quarter.
  • In the past five years, Return on Invested Capital ranged from a high of 0.07% in Q4 2021 to a low of 0.71% in Q1 2021.
  • Historically, Return on Invested Capital has averaged 0.29% across 5 years, with a median of 0.24% in 2025.
  • Biggest YoY gain for Return on Invested Capital was 62bps in 2021; the steepest drop was -60bps in 2021.
  • Year by year, Return on Invested Capital stood at 0.07% in 2021, then plummeted by -211bps to 0.22% in 2022, then crashed by -68bps to 0.37% in 2023, then rose by 24bps to 0.28% in 2024, then surged by 70bps to 0.08% in 2025.
  • Business Quant data shows Return on Invested Capital for TXG at 0.08% in Q4 2025, 0.12% in Q3 2025, and 0.14% in Q2 2025.